Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions

被引:141
|
作者
Kuljanin, J
Jankovic, I
Nedeljkovic, J
Prstojevic, D
Marinkovic, V
机构
[1] Vinca INst Nucl Sci, Lab Radiat Chem & Phys, YU-11001 Belgrade, Yugoslavia
[2] ZDRAVLJE Pharmaceut & Chem Ind, Qual Control Sector, YU-16000 Leskovac, Yugoslavia
关键词
complex formation; alendronate; iron(III) chloride; spectrophotometry;
D O I
10.1016/S0731-7085(02)00021-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The formation of the complex between alendronate, non-chromophoric bisphosphonate drug important for the treatment of a variety of bone diseases, and iron(III) chloride in perchloric acid solution was studied. The stoichiometric ratio of alendronate to Fe(III) ions in the chromophoric complex was determined to be 1:1. The conditional stability constant was log K'(ave) = 4.50 (SD = 0.15), indicating that the Fe(III)-alendronate complex is a complex of medium stability. The optimum conditions for this reaction were ascertained and a spectrophotometric method was developed for the determination of alendronate in the concentration range 8.1-162.5 mug ml(-1), the detection limit being 2 mug ml(-1). The method was validated for the direct determination of alendronate in tablet dosage formulations. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1215 / 1220
页数:6
相关论文
共 50 条
  • [21] Spectrophotometric Determination of Tiapride in Pharmaceutical Formulations
    Alarfaj, Nawal A.
    Mostafa, Azza A.
    Alghamdi, Zinah A.
    ASIAN JOURNAL OF CHEMISTRY, 2013, 25 (13) : 7433 - 7436
  • [22] Spectrophotometric determination of ezetimibe in pharmaceutical formulations
    Mishra, Pradeep
    Gupta, Alka
    Shah, Kamal
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2007, 84 (09) : 945 - 947
  • [23] Spectrophotometric determination of mizolastine in pharmaceutical formulations
    Bh, Ch Narasimharaju
    Rao, G. Devala
    ASIAN JOURNAL OF CHEMISTRY, 2008, 20 (06) : 4928 - 4930
  • [24] Spectrophotometric determination of citalopram in pharmaceutical formulations
    Sagar, GV
    ASIAN JOURNAL OF CHEMISTRY, 2004, 16 (3-4) : 1928 - 1930
  • [25] SPECTROPHOTOMETRIC DETERMINATION OF PYRITHIOXINE IN PHARMACEUTICAL FORMULATIONS
    SASTRY, CSP
    KRISHNA, DM
    ANALYTICAL LETTERS, 1995, 28 (07) : 1197 - 1207
  • [26] Spectrophotometric determination of flurazepam in pharmaceutical formulations
    Popovic, GV
    Pfendt, LB
    ANALUSIS, 1996, 24 (06) : 259 - 262
  • [27] Spectrophotometric determination of lercanidipine in pharmaceutical formulations
    Saradhi, SV
    Himabindu, V
    Rao, GD
    ASIAN JOURNAL OF CHEMISTRY, 2006, 18 (02) : 1551 - 1553
  • [28] Spectrophotometric Determination of Gemifloxacin in Pharmaceutical Formulations
    Jyothirmayee, D.
    Babu, G. Sudhakar Sai
    Rao, G. Devala
    ASIAN JOURNAL OF CHEMISTRY, 2010, 22 (02) : 1634 - 1636
  • [29] Spectrophotometric Determination of Risedronate and Etidronate in Pharmaceutical Formulations via the Molybdovanadate Method
    Walash, Mohamed I.
    Metwally, Mohamed E. -S.
    Eid, Manal I.
    El-Shaheny, Rania N.
    ANALYTICAL LETTERS, 2009, 42 (11) : 1571 - 1587
  • [30] Indirect Spectrophotometric Determination of Ibandronate in Pharmaceutical Formulations via Ligand Exchange
    Mabrouk, Mokhtar
    Hammad, Sherin F.
    Abdelaziz, Mohamed A.
    Mansour, Fotouh R.
    ANALYTICAL CHEMISTRY LETTERS, 2019, 9 (02) : 223 - 233